Search results
Results From The WOW.Com Content Network
Moxibustion carries a risk of adverse effects including burns and infection. [1] Some side effects that have been reported include nausea, throat irritation, and abdominal pain from contractions when used in pregnancy.
The drug consists of the binding fragment (Fv) of an anti-CD22 antibody fused to a toxin called PE38. [5] This toxin is a 38 kDa fragment of Pseudomonas exotoxin A. Hairy cell leukemia (HCL) is a rare, slow-growing cancer of the blood in which the bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection ...
Moxibustion has also been studied for the treatment of pain, [28] cancer, [29] stroke, [30] ulcerative colitis, [31] constipation, [32] and hypertension. [33] Systematic reviews of moxibustion show that there is a need for further research about these other therapeutic applications to reduce risk of publication bias. [34]
The Office of Cancer Complementary and Alternative Medicine (OCCAM) is an office of the National Cancer Institute (NCI) in the Division of Cancer Treatment and Diagnosis. . OCCAM was founded in 1998 and is responsible for NCI's research agenda in pseudoscientific complementary and alternative medicine (CAM), as it relates to cancer prevention, diagnosis, treatment, and symptom management
Tobacco smoking has also been shown to increase the risk of work-related cancers; decreasing or abstaining from smoking can decrease cancer risk. [ 2 ] Agencies like the US Food and Drug Administration , Environmental Protection Agency , the International Agency for Research on Cancer (IARC) and Occupational Safety and Health Administration ...
After WWII was over and the reports declassified, the experiences converged and led researchers to look for other substances that might have similar effects against cancer. The first chemotherapy drug to be developed from this line of research was mustine. Since then, many other drugs have been developed to treat cancer, and drug development ...
The risk factors that influence the extent of cardiac injury caused by anthracyclines include genetic variability, age (low or high age groups), previous treatments with cardiotoxic drugs and history of cardiac diseases. [29] Children are particularly at risk due to the anthracycline activity that can compromise the development of the immature ...
Carctol is an ineffective cancer treatment made by mixing eight Indian herbs. [1] First promoted in 1968 by Nandlal Tiwari, [1] it gained widespread popularity in United Kingdom. [2] Carctol has been aggressively marketed as being able to treat cancer and reduce the side-effects of chemotherapy.